| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/16/2009 | WO2008156661A9 BACTERIAL MEDIATED TNF-α GENE SILENCING |
| 04/16/2009 | WO2008140610A9 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast |
| 04/16/2009 | WO2008137881A9 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 04/16/2009 | WO2008136848A4 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 04/16/2009 | WO2008134646A3 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 04/16/2009 | WO2008134090A3 Yeast biocatalysts for degradation of biowarfare agents |
| 04/16/2009 | WO2008133651A3 Ablative immunotherapy |
| 04/16/2009 | WO2008127281A3 Dna-guided nanoparticle assemblies |
| 04/16/2009 | WO2008109548A4 Nucleic acid compounds for inhibiting tgfb gene expression and uses thereof |
| 04/16/2009 | WO2008076156A3 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches |
| 04/16/2009 | WO2008063755A3 Methods for hybrid corn seed production and compositions produced therefrom |
| 04/16/2009 | WO2008058752A3 Lentiviral vectors for gene transfer in quiescent (g0) cells |
| 04/16/2009 | WO2008045120A3 Transgenic mouse lines expressing human ace2 and uses thereof |
| 04/16/2009 | WO2008036638A3 Rnai modulation of scap and therapeutic uses thereof |
| 04/16/2009 | WO2008028002A9 Increasing nadph-dependent products |
| 04/16/2009 | WO2008022045A3 Differential labeling of cells |
| 04/16/2009 | WO2007094985A3 Long-acting polypeptides and methods of producing and administering same |
| 04/16/2009 | WO2007089732A3 Improvement of levels and/or sustainability of dna-based gene expression |
| 04/16/2009 | WO2007052154A3 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| 04/16/2009 | WO2007033370A3 Rc, brown pericarp and seed coat |
| 04/16/2009 | WO2007032807A3 Rice cultivar designated ‘cl131’ |
| 04/16/2009 | WO2007021733A3 Methods and compositions for enhancing protein folding |
| 04/16/2009 | WO2007018853A3 Secretion of antibodies without signal peptides from bacteria |
| 04/16/2009 | WO2007016606A3 Compositions and methods for modulating rank activities |
| 04/16/2009 | WO2007015918A3 Novel biologically active peptides and their new uses |
| 04/16/2009 | WO2007014197A3 Yeast expression vectors for production of itf |
| 04/16/2009 | WO2007010403A3 Recombinant yeasts for synthesizing epoxide hydrolases |
| 04/16/2009 | WO2007002718A3 Rnai modulation of hif-1 and theraputic uses thereof |
| 04/16/2009 | WO2007002372A3 Using cytosine deaminases to diminish retroelement transfer from pigs to humans |
| 04/16/2009 | WO2006138694A3 Rabbit monoclonal antibody against id1 protein |
| 04/16/2009 | WO2006127655A3 Enhancement of hydroxy fatty acid accumulation in oilseed plants |
| 04/16/2009 | WO2006122295A3 Methods of monitoring functional status of transplants using gene panels |
| 04/16/2009 | WO2006121951A3 Antisense antiviral compounds and methods for treating foot and mouth disease |
| 04/16/2009 | WO2006116174A3 Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase |
| 04/16/2009 | WO2006105488A3 Antibodies and related molecules that bind to 161p2f10b proteins |
| 04/16/2009 | WO2006105279A3 Defective sindbis viral vectors |
| 04/16/2009 | WO2006104778A3 Compositions and methods for detecting protease activity |
| 04/16/2009 | WO2006099620A3 Rage/diaphanous interaction and related compositions and methods |
| 04/16/2009 | WO2006098793A3 Hslim modulates immune responses |
| 04/16/2009 | WO2006093814A3 Fgf growth factor analogs |
| 04/16/2009 | WO2006083276A3 Interferon-alpha polypeptides and conjugates |
| 04/16/2009 | WO2006080937A3 Screening assays for antimicrobial agents |
| 04/16/2009 | WO2006074400A3 Method to trigger rna interference |
| 04/16/2009 | WO2006072078A3 Bioproduction of astaxanthin using mutant carotenoid ketolase and cartonenoid hydroxylase genes |
| 04/16/2009 | WO2006063116A3 Bifunctional enzyme with ϝ-glutamyleysteine synthetase and glutathione synthetase activity and uses thereof |
| 04/16/2009 | WO2006052814A3 A mortierella alpina diacylglycerol acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 04/16/2009 | WO2006045063A3 Heterologous genes for encoding polyketides |
| 04/16/2009 | WO2006044646A3 Pufa polyketide synthase systems and uses thereof |
| 04/16/2009 | WO2006042327A3 Plant-produced recombinant aprotinin and aprotinin variants |
| 04/16/2009 | WO2006036736A3 Reproductive ablation constructs |
| 04/16/2009 | WO2006032016A3 P49/strap is a novel protein involved in gene regulation and cell proliferation |
| 04/16/2009 | WO2006031291A3 A novel class of therapeutic protein based molecules |
| 04/16/2009 | WO2006017184A3 HYBRID PROTEINS WITH ErbB4 EXTRACELLULAR DOMAIN AND NEUREGULIN HEPARIN-BINDING DOMAIN FOR TARGETING |
| 04/16/2009 | WO2006012359A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/16/2009 | WO2006009676A3 Compositions and methods for enzymatic decolorization of chlorophyll |
| 04/16/2009 | WO2006007432A3 Nucleic acid molecules encoding wrinkled1-like polypeptides and methods of use in plants |
| 04/16/2009 | WO2005112567A3 Vaginal microbicide |
| 04/16/2009 | WO2005056761A3 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| 04/16/2009 | WO2005035713A3 Alternatively spliced variants of human cox1 |
| 04/16/2009 | WO2005030983A3 Amplification of polynucleotides by rolling circle amplification |
| 04/16/2009 | WO2005021705A9 Citrus sesquiterpene synthase, methods of production and uses thereof |
| 04/16/2009 | WO2005016414A3 Use of receptor sequences for immobilizing gene vectors on surfaces |
| 04/16/2009 | WO2005000006A3 Plant breeding method |
| 04/16/2009 | US20090100552 Transgenic plant transformed with stress-responsive gene |
| 04/16/2009 | US20090100551 Plant Seed Specific Promoters |
| 04/16/2009 | US20090100550 Artificial Plant Minichromosomes |
| 04/16/2009 | US20090100549 Plant galactinol synthase homologs |
| 04/16/2009 | US20090100548 Gene silencing |
| 04/16/2009 | US20090100547 Plants with improved morphogenesis and method of constructing the same |
| 04/16/2009 | US20090100546 Plants with improved morphogenesis and method of constructing the same |
| 04/16/2009 | US20090100545 Means and Methods to Modulate Flavonoid Biosynthesis in Plants and Plant Cells |
| 04/16/2009 | US20090100544 Drought Tolerant Corn with Reduced Mycotoxin |
| 04/16/2009 | US20090100543 Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use |
| 04/16/2009 | US20090100542 Promoter for epidermis-specific, pathogen-inducible transgenic expression in plants |
| 04/16/2009 | US20090100541 Transcription Factor Stress-Related Proteins and Methods of Use in Plants |
| 04/16/2009 | US20090100540 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants |
| 04/16/2009 | US20090100539 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions |
| 04/16/2009 | US20090100535 nucleic acids encoding a chimeric protein comprising a cleavage domain and a composite nucleic acid-binding region, that comprises at least two component polypeptide portions which are individually capable of binding specific nucleotide sequences |
| 04/16/2009 | US20090099379 Cold polar solvent precipitation of long chain polyunsaturated fatty acids; or eliminating low temperature haze formation |
| 04/16/2009 | US20090099378 Producing a high oil content phenotype in a plant; introducinga plant transformation vector of a nucleotide sequence encoding a sequence that encodes an ICL polypeptide, growing the transformed progenitor cells to produce a transgenic plant |
| 04/16/2009 | US20090099377 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway |
| 04/16/2009 | US20090099349 Biomarkers For Toxic Algae |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099338 Novel Protein Highly Producing Recombinant Animal Cell, Method for Preparing the Same, and Method for Mass-Producing Protein Using the Same |
| 04/16/2009 | US20090099193 Eml4-alk fusion gene |
| 04/16/2009 | US20090099125 Pan cancer oncolytic vectors and methods of use thereof |
| 04/16/2009 | US20090099124 Short interfering rna as an antiviral agent for hepatitis c |
| 04/16/2009 | US20090099123 Antisense microRNA and uses therefor |
| 04/16/2009 | US20090099120 For modulating the expression of genes associated with respiratory and pulmonary disease, such as cholinergic muscarinic receptor genes; nucleic acids with a pyrimidine modification |
| 04/16/2009 | US20090099119 RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/16/2009 | US20090099118 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/16/2009 | US20090099115 A chemically-modified nucleic acid molecule that comprises a sense strand with or without the 3' TT overhang, and a separate antisense strand with or without the 3' TT overhang; pyrimidine modification; cancer |
| 04/16/2009 | US20090099114 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099113 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099112 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099111 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099110 Antiviral oligonucleotides |
| 04/16/2009 | US20090099109 inhibition of p53 transcription by interfering with the activity of a p53 promoter using inhibitory double-stranded RNAs; use of these inhibitory RNAs in the treatment of cancers |
| 04/16/2009 | US20090099108 Oligonucleotide decoys and methods of use |
| 04/16/2009 | US20090099107 Methods and Compositions for Inhibition of Nuclear Factor kappaB |